TY - JOUR
T1 - Corrigendum to ‘Impact of COVID-19 on immunocompromised populations during the Omicron era
T2 - insights from the observational population-based INFORM study’ [The Lancet Regional Health – Europe 35 (2023) 100747] (The Lancet Regional Health - Europe (2023) 35, (S2666776223001667), (10.1016/j.lanepe.2023.100747))
AU - Evans, Rachael A.
AU - Dube, Sabada
AU - Lu, Yi
AU - Yates, Mark
AU - Arnetorp, Sofie
AU - Barnes, Eleanor
AU - Bell, Samira
AU - Carty, Lucy
AU - Evans, Kathryn
AU - Graham, Sophie
AU - Justo, Nahila
AU - Moss, Paul
AU - Venkatesan, Sudhir
AU - Yokota, Renata
AU - Ferreira, Catia
AU - McNulty, Richard
AU - Taylor, Sylvia
AU - Quint, Jennifer K.
N1 - Funding: This study was funded by AstraZeneca LTD UK.
PY - 2024/9
Y1 - 2024/9
N2 - The authors have noticed an error at the end of the Outcomes paragraph in the Methods section, where it currently reads ‘COVID-19-related mortality, defined as a death in ONS mortality data with COVID-19 recorded as a cause of death, or an in-hospital death during a COVID-19 hospitalisation.’ This should be replaced with ‘COVID-19-related mortality, defined as a death in ONS mortality data with COVID-19 recorded as a cause of death.’
AB - The authors have noticed an error at the end of the Outcomes paragraph in the Methods section, where it currently reads ‘COVID-19-related mortality, defined as a death in ONS mortality data with COVID-19 recorded as a cause of death, or an in-hospital death during a COVID-19 hospitalisation.’ This should be replaced with ‘COVID-19-related mortality, defined as a death in ONS mortality data with COVID-19 recorded as a cause of death.’
UR - https://www.scopus.com/pages/publications/85199479433
U2 - 10.1016/j.lanepe.2024.101008
DO - 10.1016/j.lanepe.2024.101008
M3 - Comment/debate
AN - SCOPUS:85199479433
SN - 2666-7762
VL - 44
SP - 1
EP - 1
JO - The Lancet Regional Health - Europe
JF - The Lancet Regional Health - Europe
M1 - 101008
ER -
SDG 3 Good Health and Well-being